bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
4.080
+0.290 (7.65%)
At close: Mar 28, 2025, 4:00 PM
4.450
+0.370 (9.07%)
After-hours: Mar 28, 2025, 7:59 PM EDT
bluebird bio Stock Forecast
BLUE's stock price has decreased by -85.05% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for bluebird bio stock have an average target of 51, with a low estimate of 5.00 and a high estimate of 120. The average target predicts an increase of 1,150.00% from the current stock price of 4.08.
Analyst Consensus: Hold
* Price targets were last updated on Feb 24, 2025.
Analyst Ratings
The average analyst rating for bluebird bio stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 6 | 7 | 6 | 6 | 6 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $40 → $5 | Hold | Maintains | $40 → $5 | +22.55% | Feb 24, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Feb 24, 2025 |
| Barclays | Barclays | Buy Maintains $2 → $40 | Buy | Maintains | $2 → $40 | +880.39% | Dec 31, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +1,860.78% | Nov 15, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $60 → $10 | Strong Buy → Hold | Downgrades | $60 → $10 | +145.10% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
258.59M
from 83.81M
Increased by 208.55%
Revenue Next Year
309.77M
from 258.59M
Increased by 19.79%
EPS This Year
-9.79
EPS Next Year
-11.73
from -9.79
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 403.0M | 432.6M | 445.7M | ||
| Avg | 258.6M | 309.8M | 369.5M | ||
| Low | 147.1M | 220.5M | 294.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 380.9% | 67.3% | 43.9% | ||
| Avg | 208.6% | 19.8% | 19.3% | ||
| Low | 75.5% | -14.7% | -5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.68 | -5.25 | -0.43 | ||
| Avg | -9.79 | -11.73 | -0.47 | ||
| Low | -23.13 | -17.64 | -0.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.